Loading
Interventional Pulmonology
Most Read Articles
Association between the prevalence of obstructive lung disease and the use of aspirin in a diabetic population
Maria E Ramos-Nino , Charles D MacLean , Benjamin Littenberg
Aspirin (acetylsalicylic acid), a non-steroidal anti-inflammatory drug, inhibits cyclooxygenases (COX-1 and COX-2), which catalyze the conversion of arachidonic acid to prostaglandins. In control environments, low-dose aspirin (75 mg or 81 mg) inhibits COX-1 and disrupts the production of thromboxane, reducing platelet aggregation
Interv Pulmonol, 2023, Volume 1, Issue 1, p5-10 | DOI: 10.46439/Pulmonology.1.002